First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model - Concepedia

Concepedia

Publication | Open Access

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

DOI Full Paper Access

243

Citations

24

References

2014

Year

Eva Kontseková, Norbert Žilka, Branislav Kováčech, Petr Novák, Michal Novák

Alzheimer s Research & Therapy

Abstract

Current Controlled Trials NCT01850238. Registered 7 May 2013.

References

	Year	Citations

Page 1